132 related articles for article (PubMed ID: 36993653)
1. Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS).
Badachhape AA; Burnett B; Bhandari P; Devkota L; Bhavane R; Ghaghada KB; Yallampalli C; Fox KA; Annapragada AV
medRxiv; 2023 Mar; ():. PubMed ID: 36993653
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS).
Badachhape AA; Bhandari P; Devkota L; Srivastava M; Tanifum EA; George V; Fox KA; Yallampalli C; Annapragada AV; Ghaghada KB
Acad Radiol; 2023 Jul; 30(7):1384-1391. PubMed ID: 36167627
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation.
Badachhape AA; Kumar A; Ghaghada KB; Stupin IV; Srivastava M; Devkota L; Starosolski Z; Tanifum EA; George V; Fox KA; Yallampalli C; Annapragada AV
Placenta; 2019 Feb; 77():1-7. PubMed ID: 30827350
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta.
Ghaghada KB; Starosolski ZA; Bhayana S; Stupin I; Patel CV; Bhavane RC; Gao H; Bednov A; Yallampalli C; Belfort M; George V; Annapragada AV
Placenta; 2017 Sep; 57():60-70. PubMed ID: 28864020
[TBL] [Abstract][Full Text] [Related]
5. Ferumoxytol-enhanced MR demonstration of changes to internal placental structure in placenta accreta spectrum: Preliminary findings.
Kliewer MA; Bockoven CG; Reeder SB; Bagley AR; Sadowski EA; Iruretagoyena JI; Beninati MJ; Fritsch MK
Placenta; 2023 Mar; 134():1-8. PubMed ID: 36807998
[TBL] [Abstract][Full Text] [Related]
6. The maximum length of T2-dark intraplacental bands may help predict intraoperative haemorrhage in pregnant women with placenta accreta spectrum (PAS).
Wu X; Zhou R; Lin M; Li Y; Ying W; Li L; Ji W; Zheng K
Abdom Radiol (NY); 2022 Oct; 47(10):3594-3603. PubMed ID: 35896684
[TBL] [Abstract][Full Text] [Related]
7. Predicting Placenta Accreta Spectrum Disorders in a Cohort of Pregnant Patients in the North-East Region of Romania-Diagnostic Accuracy of Ultrasound and Magnetic Resonance Imaging.
Haba RM; Pristavu AI; Cobzeanu ML; Carauleanu A; Sadiye Scripcariu I; Vasilache IA; Minciuna DA; Negru D; Socolov DG
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140531
[TBL] [Abstract][Full Text] [Related]
8. Intraplacental T2-hypointense bands may help predict placental invasion depth and postpartum hemorrhage in placenta accrete spectrum disorders in high-risk gravid patients.
Hu Y; Wang Y; Weng Q; Wu X; Xia S; Wang H; Cheng X; Mao C; Li X; Zhou Z; Chen C; Xu M; Wang Z; Ji J
Magn Reson Imaging; 2022 Dec; 94():73-79. PubMed ID: 36116713
[TBL] [Abstract][Full Text] [Related]
9. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
[TBL] [Abstract][Full Text] [Related]
10. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
[TBL] [Abstract][Full Text] [Related]
11. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
[TBL] [Abstract][Full Text] [Related]
12. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
[No Abstract] [Full Text] [Related]
13. Prenatal ultrasound staging system for placenta accreta spectrum disorders.
Cali G; Forlani F; Lees C; Timor-Tritsch I; Palacios-Jaraquemada J; Dall'Asta A; Bhide A; Flacco ME; Manzoli L; Labate F; Perino A; Scambia G; D'Antonio F
Ultrasound Obstet Gynecol; 2019 Jun; 53(6):752-760. PubMed ID: 30834661
[TBL] [Abstract][Full Text] [Related]
14. Super High Contrast USPIO-Enhanced Cerebrovascular Angiography Using Ultrashort Time-to-Echo MRI.
Timms L; Zhou T; Qiao J; Gharagouzloo C; Mishra V; Lahoud RM; Chen JW; Harisinghani M; Sridhar S
Int J Biomed Imaging; 2024; 2024():9763364. PubMed ID: 38644981
[TBL] [Abstract][Full Text] [Related]
15. Placenta accreta spectrum: value of placental bulge as a sign of myometrial invasion on MR imaging.
Jha P; Rabban J; Chen LM; Goldstein RB; Weinstein S; Morgan TA; Shum D; Hills N; Ohliger MA; Poder L
Abdom Radiol (NY); 2019 Jul; 44(7):2572-2581. PubMed ID: 30968183
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion MR imaging analysis for diagnosis of placenta accrete spectrum disorders: A pilot feasibility study.
León RL; Brown BP; Persohn SA; Norris CD; Steinhardt NP; Lin C; Territo PR
Magn Reson Imaging; 2021 Jul; 80():26-32. PubMed ID: 33766730
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.
Cavalli C; Maggi C; Gambarini S; Fichera A; Santoro A; Grazioli L; Prefumo F; Odicino FE; Fratelli N
J Perinat Med; 2022 Mar; 50(3):277-285. PubMed ID: 34854274
[TBL] [Abstract][Full Text] [Related]
18. Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders.
Bourgioti C; Konstantinidou AE; Zafeiropoulou K; Antoniou A; Fotopoulos S; Theodora M; Daskalakis G; Nikolaidou ME; Tzavara C; Letsika A; Martzoukos EA; Moulopoulos LA
Radiology; 2021 Feb; 298(2):403-412. PubMed ID: 33231529
[TBL] [Abstract][Full Text] [Related]
19. MRI of the Placenta Accreta Spectrum (PAS) Disorder: Radiomics Analysis Correlates With Surgical and Pathological Outcome.
Do QN; Lewis MA; Xi Y; Madhuranthakam AJ; Happe SK; Dashe JS; Lenkinski RE; Khan A; Twickler DM
J Magn Reson Imaging; 2020 Mar; 51(3):936-946. PubMed ID: 31397528
[TBL] [Abstract][Full Text] [Related]
20. Quantifying magnetic resonance imaging features to classify placenta accreta spectrum (PAS) in high-risk gravid patients.
Chu C; Liu M; Zhang Y; Yu L; Wang D; Gao C; Li W
Clin Imaging; 2021 Dec; 80():50-57. PubMed ID: 34242814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
